NewAmsterdam Pharma Company NAMS Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from NewAmsterdam Pharma Company’s reported figures.
Based on trailing twelve months.
The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about NewAmsterdam Pharma Company's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NewAmsterdam Pharma Company's operating margin?
- NewAmsterdam Pharma Company (NAMS) reported operating margin of -953.6% in Q1 2026.
- How has NewAmsterdam Pharma Company's operating margin changed year-over-year?
- NewAmsterdam Pharma Company's operating margin decreased by 136.9% year-over-year, from -402.5% to -953.6%.
- What is the long-term trend for NewAmsterdam Pharma Company's operating margin?
- Over 3 years (2022 to 2025), NewAmsterdam Pharma Company's operating margin has grown at a 561.6% compound annual growth rate (CAGR), from -3.5% to -1,002.9%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.